A carregar...

Assessment of Minimal Residual Disease in Myeloma and the Need for a Consensus Approach

Treatment options for myeloma continue to develop at a rapid pace, and it is becoming increasingly challenging to determine the optimal therapeutic approaches because demonstrating a clear survival benefit now requires many years of follow-up. The detection of minimal residual disease (MRD) is recog...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cytometry B Clin Cytom
Main Authors: Rawstron, Andy C., Paiva, Bruno, Stetler-Stevenson, Maryalice
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7511969/
https://ncbi.nlm.nih.gov/pubmed/26202864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cyto.b.21272
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!